How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism

Demystifying the Benefits and Harms of Anticoagulation for Atrial Fibrillation in Chronic Kidney Disease

(2019) Katherine G. Garlo et al.   Clinical Journal of the American Society of Nephrology

Antithrombotic Therapy for Atrial Fibrillation

(2018) Gregory Y.H. Lip et al.   CHEST

Cerebral Amyloid Angiopathy

(2017) Christopher V. DeSimone et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale

(2017) Alex Spyropoulos et al.   THROMBOSIS AND HAEMOSTASIS

Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub‐Analysis From the PREFER in AF ( PRE vention o F Thromboembolic Events– E uropean R egistry in A trial F ibrillation)

(2017) Giuseppe Patti et al.   Journal of the American Heart Association

Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?

(2016) Endalkachew A. Alamneh et al.   American Journal of Cardiovascular Drugs

Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy

(2016) Megan E. Barra et al.   AMERICAN JOURNAL OF MEDICINE

Evolving Treatments for Arterial and Venous Thrombosis

(2016) Noel C. Chan et al.   CIRCULATION RESEARCH

Direct Oral Anticoagulants for the Management of Thromboembolic Disorders

(2016) Alpesh Amin et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPEAN HEART JOURNAL

Causes of Death in Anticoagulated Patients With Atrial Fibrillation

(2016) Antonio Gómez-Outes et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF

(2016) Kevin E. Chan et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial

(2016) Eri Toda Kato et al.   Journal of the American Heart Association

Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation

(2016) Xiaoxi Yao et al.   Journal of the American Heart Association

How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society

(2015) David J. Gladstone et al.   ANNALS OF INTERNAL MEDICINE

Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation

(2015) Hein Heidbuchel et al.   EUROPACE

Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding

(2015) Chatree Chai-Adisaksopha et al.   THROMBOSIS AND HAEMOSTASIS

Interventional tools to improve medication adherence: review of literature

(2015) Elísio Costa et al.   Patient Preference and Adherence

Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study

(2015) Laila Staerk et al.   BMJ-British Medical Journal

Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study

(2015) Laila Staerk et al.   BMJ-British Medical Journal

Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012

(2014) Paul L. Hess et al.   AMERICAN HEART JOURNAL

Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

(2014) Jonathan L. Halperin et al.   CIRCULATION

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2014) Craig T. January et al.   CIRCULATION

Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

(2014) S. Halvorsen et al.   EUROPEAN HEART JOURNAL

Restarting Anticoagulation and Outcomes After Major Gastrointestinal Bleeding in Atrial Fibrillation

(2013) Waqas Qureshi et al.   AMERICAN JOURNAL OF CARDIOLOGY

Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin

(2013) Stavros Apostolakis et al.   CHEST

Worldwide Epidemiology of Atrial Fibrillation

(2013) Sumeet S. Chugh et al.   CIRCULATION

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

(2012) Leif Friberg et al.   EUROPEAN HEART JOURNAL

Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease

(2012) Jonas Bjerring Olesen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review

(2011) Dan Pugh et al.   AGE AND AGEING

A Systematic Review of Barriers to Medication Adherence in the Elderly: Looking Beyond Cost and Regimen Complexity

(2011) Walid F. Gellad et al.   American Journal Geriatric Pharmacotherapy

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation

(2011) John W. Eikelboom et al.   CIRCULATION

Apixaban in Patients with Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review

(2010) Isla M. Ogilvie et al.   AMERICAN JOURNAL OF MEDICINE

Venous Thromboembolism

(2010) Michele G. Beckman et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Venous thrombosis in the elderly: incidence, risk factors and risk groups

(2010) M. J. ENGBERS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Racial Disparities in Awareness and Treatment of Atrial Fibrillation

(2010) James F. Meschia et al.   STROKE

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation

(2009) Carl van Walraven et al.   STROKE

Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range

(2008) Stuart J. Connolly et al.   CIRCULATION

Potentially Preventable Strokes in High-Risk Patients With Atrial Fibrillation Who Are Not Adequately Anticoagulated

(2008) David J. Gladstone et al.   STROKE

Venous thromboembolism in the elderly

(2008) Joel M. Gore et al.   THROMBOSIS AND HAEMOSTASIS